What tirzepatide injections cost in the UK — and what drives the price

Free clinical consultation, reviewed the same day by a GPhC-registered Independent Prescriber
Prescription included, no separate charge, no add-on fees
Free next-working-day tracked delivery by DPD, in plain unbranded packaging
Priority aftercare seven days a week, with clinical re-review before every repeat order

Private tirzepatide injections in the UK are priced per pen, per month, and vary between providers depending on the dose and what the headline figure actually covers. Since Eli Lilly raised its UK list price on 1 September 2025, reported private costs have ranged from roughly £149 to £375 a month, rising with each dose step — though individual providers set their own rates. Tirzepatide is a prescription-only medicine, so any legitimate price must include clinical assessment by a qualified prescriber; no online service can legally supply it otherwise. If you've been comparing quotes and the numbers look confusing, that's because they often are, the sticker price and the total cost are not always the same thing.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The full picture on tirzepatide pricing: what the evidence says, what headline quotes leave out, and how to read them

Where the current price range comes from

Tirzepatide's UK pricing shifted substantially from autumn 2025. Eli Lilly, the medicine's manufacturer, revised its UK list price upward on 1 September 2025: the highest-dose pen moved from around £122 to around £330 at list level, and private providers adjusted their own rates accordingly. As widely reported at the time, the private market now sits roughly between £149 and £375 per four-week pen, varying by dose and by clinic. These figures are background context rather than shopping data, because the dose you'd be prescribed (if tirzepatide is clinically suitable for you at all) is a decision your prescriber makes, not one you can fix in advance.

The NICE technology appraisal of tirzepatide (TA1026) confirmed the medicine's clinical value for eligible adults, and the same clinical programme that underpinned that decision recorded average weight reductions of around 20–21% over 72 weeks at the highest dose in SURMOUNT-1. That evidence makes tirzepatide the most effective weight-loss medicine currently licensed in the UK, which partly explains why the pricing reflects it. If you want a more detailed breakdown of what the tirzepatide injection price looks like across different doses and providers, our dedicated page runs through the specifics.

What headline prices often leave out

A quote for tirzepatide can be honest about the pen's cost while being silent about the other elements that a safe treatment actually requires. Consultation fees are common, some services charge £20 to £50 or more for the clinical assessment, billed separately from the medicine. Prescription fees, delivery charges and aftercare access can each carry their own line item. The total, by the time you've added them up, can exceed a provider whose headline price looked higher.

There's also the question of what happens between orders: dose increase reviews, clinical re-assessment before each repeat, and someone to contact if you experience side effects. The NHS's tirzepatide medicines page lists the side-effect profile plainly, nausea, gastrointestinal symptoms and injection-site reactions are common at dose increases, and having prescriber access in those moments matters. A service that only charges for the pen but doesn't include ongoing clinical support is not cheaper; it's incomplete. If you want to understand what Mounjaro injections price looks like once all the components are accounted for, that page covers what those costs typically include.

Why nume is deliberately not the cheapest option

We don't compete on price, and we don't apologise for that. At nume, one transparent amount covers the consultation, prescription, medicine, next-working-day DPD delivery and seven-day aftercare, no surprises at checkout, no subscription locking you in, no auto-renewals. Every repeat order is clinically reviewed before it goes out. A real clinician reads your consultation; not software, not a templated form with a rubber stamp at the end.

Our GPhC-registered pharmacy (registration number 9012878, verifiable on the GPhC register) sources tirzepatide through the authorised UK supply chain. If you order before noon on a working day and your prescriber approves treatment, your pen ships the same day. That combination (genuine safety infrastructure, included aftercare, and tracked discreet delivery) is what the price reflects. To see current treatment pricing, visit our treatment page. You can also read about how tirzepatide works before deciding whether to proceed.

For a prescription medicine, price is the wrong test

The counterfeit market for weight-loss injections in the UK is not a fringe problem. The MHRA has made Yellow Card reporting available specifically for suspect medicines and sellers, and enforcement activity through 2025 resulted in approximately 20 million doses of illegally traded weight-loss medicines (around £45 million street value) being seized, including a UK manufacturing site producing fake tirzepatide pens. If you are trying to understand how much Mounjaro injections cost through legitimate channels before making any decisions, that page sets out what you can realistically expect to pay. Pens sold through social media, or marketed as the cheapest Mounjaro injections available, or provided without any clinical assessment carry a real risk of containing something other than the medicine on the label.

The right metric for a prescription-only medicine is not the lowest price; it's whether the supply chain is legitimate, whether a qualified prescriber assessed your suitability, and whether you have clinical support if something goes wrong. Our about us page explains how nume is structured to meet those standards, and if you have questions before starting, our FAQs cover the most common ones. When you're ready, start your free consultation and a prescriber will review your answers the same day. You can also visit our dedicated page if you want a fuller picture of what tirzepatide costs across the private market before committing to a provider.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions